CASEY BAER: Open Payments
NPI 1154082444 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 68 payments from 18 companies in 2025. Trend: 2023 $344 · 2024 $743 · 2025 $1,238
Food & beverage: $1,238
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $188 |
| Novo Nordisk Inc | 10 | $175 |
| PFIZER INC. | 11 | $135 |
| Dexcom, Inc. | 3 | $103 |
| AstraZeneca Pharmaceuticals LP | 6 | $98 |
| Smith+Nephew, Inc. | 3 | $72 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Exact Sciences Corporation | 3 | $59 |
| Xeris Pharmaceuticals, Inc. | 3 | $57 |
| CeQur Corporation | 1 | $54 |
Products named: VRAYLAR, Dexcom G6 Transmitter, AIRSUPRA, ELIQUIS, COLLAGENASE SANTYL, TRELEGY ELLIPTA, Wegovy, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
